Publication | Closed Access
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis
86
Citations
31
References
2008
Year
The data demonstrate that AS602868-mediated IKK2 inhibition represents a new therapeutic approach to prevent dietary-induced NASH progression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1